Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Abstract Background Staphylococcus aureus bacteremia is associated with significant morbidity and mortality. To treat this infection, the current standard of care includes intravenous anti-staphylococcal beta-lactam antibiotics and obtaining adequate source control. Combination therapy with an amino...

Full description

Bibliographic Details
Main Authors: Matthew P. Cheng, Alexander Lawandi, Guillaume Butler-Laporte, Katryn Paquette, Todd C. Lee
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Trials
Subjects:
Daptomycin
Staphylococcus aureus
Bacteremia
Beta-lactam
Online Access:http://link.springer.com/article/10.1186/s13063-018-2668-6

Internet

http://link.springer.com/article/10.1186/s13063-018-2668-6

Similar Items